Clinical Research Directory
Browse clinical research sites, groups, and studies.
Electronic MonitorIng of Events for dIffuse Large b Cell LYmphoma
Sponsor: Weprom
Summary
Diffuse large B cell lymphoma is the most common malignant lymphoid hemopathy. More than half of the patients will be cured with an RCHOP-type immunochemotherapy protocol (Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, Prednisone). Monitoring of adverse effects, risk of relapse and quality of life are essential in overall management. Patients are the best candidates to report them. Managing these events should improve quality of life and reduce costs. The aim of this study is to assess the feasibility of monitoring these events by a web application (Oncolaxy©) and to compare it with a control population in the context of a randomized pilot study including 80 patients per arm with diffuse large cell B lymphoma in first-line treatment with R-CHOP.
Official title: Evaluation of a Web Application on Event Reporting for Patients With B Lymphoma on First Line Treatment
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
160
Start Date
2022-07-01
Completion Date
2026-12-01
Last Updated
2022-04-05
Healthy Volunteers
No
Conditions
Interventions
ONCOLAXY Follow-up
The operation of Oncolaxy© is based on the principle of e-PRO (electronic patient reported outcome) which is able to assess the symptoms declared by patients treated for cancer, to detect an evolution, a recurrence or the toxicity of a therapy. Alerts are sent to the healthcare team if the algorithm detects suspicious symptoms or worsening of these symptoms. Oncolaxy© records symptoms using an electronic questionnaire that allows them to be graded. Questionnaires are sent out on a regular basis. The algorithm analyzes the responses and processes them taking into account the score of the response and its evolution over time. The combination of the results makes it possible to send information to the healthcare teams in charge of the patient that will alert them, enlighten them and help them guide their decisions which remain under their sole control. The summary of the results can be viewed at any time on a dashboard.
Locations (5)
Polyclinique Bordeaux Nord Aquitaine
Bordeaux, France
Clinique Victor Hugo/Centre Jean Bernard/ILC
Le Mans, France
Hôpital Privée du Confluent
Nantes, France
Centre Hospitalier de St Nazaire
Saint-Nazaire, France
Centre de radiothérapie de Robertsau
Strasbourg, France